BRO vs STRO
Brown & Brown Inc (BRO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. STRO currently screens at market cap $470.8M.
Not investment advice. Open the BRO and STRO stock pages for the full models.
Not investment advice.